Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (622) Arrow Down
Filter Results: (622) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (622)
    • People  (2)
    • News  (57)
    • Research  (449)
    • Events  (2)
    • Multimedia  (8)
  • Faculty Publications  (395)

Show Results For

  • All HBS Web  (622)
    • People  (2)
    • News  (57)
    • Research  (449)
    • Events  (2)
    • Multimedia  (8)
  • Faculty Publications  (395)
← Page 22 of 622 Results →
  • November 1985
  • Case

Genetics Institute Enters the Seed Business

By: Ray A. Goldberg and Michael Joseph Kennedy
Keywords: Competitive Strategy; Biotechnology Industry
Citation
Find at Harvard
Related
Goldberg, Ray A., and Michael Joseph Kennedy. "Genetics Institute Enters the Seed Business." Harvard Business School Case 586-077, November 1985.
  • November 1978 (Revised February 1990)
  • Case

Amicon Corp. (C)

Details the negotiations between Amicon and one potential licensee, Jackson. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Citation
Educators
Purchase
Related
Capon, Noel. "Amicon Corp. (C)." Harvard Business School Case 579-095, November 1978. (Revised February 1990.)
  • 06 Oct 2020
  • Blog Post

2+2 Where Are They Now Spotlight: Curtis Wu (MBA 2018)

Can you describe your role?I currently work at Amgen Inc at their global HQ in Southern California. Amgen is the largest independent biotechnology company in the world by revenue and our top medicines include autoimmune drug Enbrel, white... View Details
  • 01 Aug 2002
  • News

For Alumni Only: Breakthrough Insights Program Debuts

case on the biotechnology firm Biogen, where a seemingly innocuous decision to license databases of new proteins discovered through genomic research wound up completely transforming the company's product-development process. As Vietor led... View Details
Keywords: Laura Singleton
  • 01 Feb 1999
  • News

Classmates Rally to Help Family Stricken with Rare Disease

scientists and researchers, in conjunction with several biotechnology companies, including Genzyme Corp., are now ready to test on humans an enzyme replacement therapy that has been successful in reversing the disease in laboratory... View Details
  • 29 Jun 2022
  • Blog Post

Harvard Business School Announces the 2022-2023 Blavatnik Fellows

led by Peter Barrett, PhD, faculty chair, and an advisory board of seasoned business and biotechnology leaders who serve as one-on-one mentors and provide strategic direction during the fellows' program year. “Since joining the Blavatnik... View Details
  • 02 Aug 2004
  • Research & Ideas

Health Care Research and Prospects

is a lot other work at the school going on around these issues by many other faculty. For instance, Dave Scharfstein is doing great work on how capital market forces influence the development strategies of biotechnology companies. David... View Details
Keywords: by Wendy Guild Swearingen; Health
  • 07 Jul 2003
  • Research & Ideas

The Organizational Model for Open Source

The more fundamental question that firms and policy makers need to be thinking about is just what type of good is software?—Siobhán O'Mahony Similar issues surface in the biotechnology world, where university and market conceptions of the... View Details
Keywords: by Mallory Stark
  • 12 Oct 1999
  • Research & Ideas

Porter’s Perspective: Competing in the Global Economy

therefore, become unique local centers of innovation for the likes of mutual funds, venture capital, and biotechnology in Greater Boston or aircraft equipment and design, boat and shipbuilding, and metal fabrication in Seattle. The list... View Details
Keywords: Re: Michael E. Porter
  • Research Summary

Evolution of firm structure in vertical specialized technology supply chains

By: Willy C. Shih
The global market in many everyday products has been transformed by the internationalization of production.  In many industries, semiconductors and electronic products in particular, a sequential mode of production has evolved in which goods are produced... View Details
Keywords: Globalization Of Supply Chain; Globalization; Technological Innovation; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States; Asia; China
  • Research Summary

Industrial competitiveness in high tech and science-based businesses

By: Willy C. Shih
How do emerging economies develop industrial and technical capabilities that overtake those of advanced economies?  Are there some industrial sectors that are especially susceptible to such targeting?  What will it take to restore America’s... View Details
Keywords: Technological Innovation; Technology Diffusion; Knowledge Flows; Competitive Advantage; Globalization; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States; China; Asia
  • September 2019
  • Case

Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem

By: Willy C. Shih
Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and its critical role in public health made its production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine... View Details
Keywords: Vaccine; Production; Supply Chain; Product; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Belgium
Citation
Educators
Purchase
Related
Shih, Willy C. "Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem." Harvard Business School Case 620-021, September 2019.
  • June 2010
  • Teaching Note

Monsanto: Helping Farmers Feed the World (TN)

By: David E. Bell and Mary Louise Shelman
Teaching Note for [510025]. View Details
Keywords: Food; Production; Adoption; Leadership Style; Globalized Markets and Industries; Performance Productivity; Biotechnology Industry; Biotechnology Industry
Citation
Purchase
Related
Bell, David E., and Mary Louise Shelman. "Monsanto: Helping Farmers Feed the World (TN)." Harvard Business School Teaching Note 510-101, June 2010.
  • March 2010 (Revised May 2012)
  • Case

Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration

By: Karim R. Lakhani and Paul R. Carlile
This case presents the Myelin Repair Foundation's accelerated research collaboration model for drug discovery. It highlights the challenges of building a multi-disciplinary and multi-institutional research collaboration that is attempting to create a treatment for... View Details
Keywords: Research and Development; Intellectual Property; Risk and Uncertainty; Strategic Planning; Collaborative Innovation and Invention; Health Disorders; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry
Citation
Educators
Purchase
Related
Lakhani, Karim R., and Paul R. Carlile. "Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration." Harvard Business School Case 610-074, March 2010. (Revised May 2012.)
  • April 2008
  • Teaching Note

Viagen: Revolutioning the Livestock Industry (TN)

By: David E. Bell, Mary L. Shelman and Eliot Sherman
Teaching Note for [507021]. View Details
Keywords: Investment; Genetics; Production; Training; Customers; Supply Chain; Business Plan; Commercialization; Information Technology; Performance Efficiency; Governing Rules, Regulations, and Reforms; Industry Structures; Biotechnology Industry; Biotechnology Industry
Citation
Purchase
Related
Bell, David E., Mary L. Shelman, and Eliot Sherman. "Viagen: Revolutioning the Livestock Industry (TN)." Harvard Business School Teaching Note 508-014, April 2008.
  • March 2007
  • Teaching Note

Monsanto: Realizing Biotech Value in Brazil (TN)

By: David E. Bell and Mary L. Shelman
Keywords: Value; Biotechnology Industry; Biotechnology Industry; Brazil
Citation
Purchase
Related
Bell, David E., and Mary L. Shelman. "Monsanto: Realizing Biotech Value in Brazil (TN)." Harvard Business School Teaching Note 507-059, March 2007.
  • December 2006 (Revised January 2008)
  • Case

ViaGen: Revolutionizing the Livestock Industry

By: David E. Bell, Reed Martin and Mary L. Shelman
ViaGen has invested heavily to develop cloning technology for the livestock industry. Cloning has the potential to significantly improve the genetics of livestock, leading to higher quality meat, healthier animals, and more efficient production. Since 2003, the firm... View Details
Keywords: Animal-Based Agribusiness; Business Plan; Governing Rules, Regulations, and Reforms; Marketing Communications; Industry Structures; Business and Government Relations; Genetics; Commercialization; Biotechnology Industry; Biotechnology Industry
Citation
Educators
Purchase
Related
Bell, David E., Reed Martin, and Mary L. Shelman. "ViaGen: Revolutionizing the Livestock Industry." Harvard Business School Case 507-021, December 2006. (Revised January 2008.)
  • September 1990 (Revised November 1990)
  • Case

DNAP: Looking to the Nineties

By: Ray A. Goldberg
Keywords: Marketing; Product Positioning; Biotechnology Industry; Biotechnology Industry
Citation
Find at Harvard
Related
Goldberg, Ray A. "DNAP: Looking to the Nineties." Harvard Business School Case 591-032, September 1990. (Revised November 1990.)
  • November 2023 (Revised April 2024)
  • Case

BiomX: Bringing Phage Back to the Stage

By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Biotechnology Industry
Citation
Educators
Purchase
Related
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
  • September 2023 (Revised April 2024)
  • Case

Atomwise: Strategic Opportunities in AI for Pharma

By: Satish Tadikonda
Abraham Heifets and his co-founder, Izhar Wallach, had founded Atomwise to develop i) an AI engine to transform drug discovery by creating better medicines faster, and ii) a machine learning-based discovery engine that combined the power of convolutional neural... View Details
Keywords: Business Model; Business Startups; AI and Machine Learning; Science-Based Business; Technological Innovation; Biotechnology Industry; Biotechnology Industry
Citation
Educators
Purchase
Related
Tadikonda, Satish. "Atomwise: Strategic Opportunities in AI for Pharma." Harvard Business School Case 824-043, September 2023. (Revised April 2024.)
  • ←
  • 22
  • 23
  • …
  • 31
  • 32
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.